Accelerated access to novel cancer therapies at Moores Cancer Center
The EY Clinical Trial Fast Lane solution is designed to activate clinical trials in 45 to 60 working days through rapid performance of functional services, process excellence, deep understanding of clinical trial operations, real-time transparency across all involved stakeholders and prompt risk mitigation.
The EY Clinical Trial Fast Lane solution enabled Moores Cancer Center to accelerate activation of its highest priority clinical trials and implement related process improvements to improve clinical trial activation timelines across all clinical trials. As a result, MCC patients had access to these innovative, investigational treatments and therapies up to 11 times faster than traditional timelines for the institution.
Related Reading
News / Business Development / Diagnostics / Health Access
Scott Garrett Named 2026 Recipient of AdvaMedDx® Lifetime of Leadership & Service Award
October 19, 2026
BOSTON—AdvaMed, the Medtech Association, today announced Scott Garrett as the 2026 recipient of the AdvaMedDx Lifetime of Leadership & Service Award, honoring his more than 45 years of leadership across diagnostics, life sciences, medical products, specialty distribution, and laboratory services.
News / Business Development / Diagnostics / Health Access
AdvaMed Names Vince Forlenza 2026 Lifetime Achievement Award Winner
October 16, 2026
WASHINGTON, D.C.—AdvaMed®, the Medtech Association, today announced Vincent A. “Vince” Forlenza, former chairman and CEO of BD (Becton, Dickinson and Company), as the recipient of the 2026 AdvaMed Lifetime Achievement Award. Forlenza will receive the award during The MedTech Conference in Boston Oct. 18-21.
Blog / Business Development / Small Business / The MedTech Conference
AdvaMed® in Action: Where Emerging Medtech Leaders Go Next
September 22, 2026
JC Scott shares how AdvaMed Accel priorities—from raising capital to building a stronger path to commercialization—will come to life at #MTC26 in Boston.
Event / AdvaMed Advancements / Business Development / Government & Legislative Affairs / Regulatory Affairs / Small Business
Medtech Showcase & Reception on Capitol Hill
September 16, 2026
5:00 PM – 7:00 PM
Experience the future of health care at the 2026 Medtech Showcase and Reception on Capitol Hill. Join AdvaMed® on September 16 for an interactive event featuring more than 25 medtech companies demonstrating breakthrough technologies that are transforming patient care. See innovative medical devices firsthand, connect with industry leaders and policymakers, and discover how medtech innovation is improving and saving lives.
Blog / Business Development / Health Access / Small Business
Pro-Innovation Tax Policy Strengthens U.S. Medtech Leadership, Delivers for Patients
April 15, 2026
The tax incentives in the One Big Beautiful Bill Act passed by Congress and signed into law by President Trump last year are a prime example of the public policies reinforcing the U.S. position as the global leader in medtech innovation.
News / Business Development / Government & Legislative Affairs / Small Business
AdvaMed Thanks President Trump, Congress for Legislation Restoring Programs That Jumpstart Early-stage Medtech Innovation
April 14, 2026
WASHINGTON—AdvaMed, the Medtech Association, the largest trade association representing medtech innovators, thanked President Trump and Congress for enacting the Small Business Innovation and Economic Security Act (S. 3971). Signed into law, the legislation reauthorizes the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
News / Business Development / Government & Legislative Affairs / Small Business
AdvaMed Welcomes House Passage of Legislation Restoring Programs That Jumpstart Early-stage Medtech Innovation
March 17, 2026
WASHINGTON—AdvaMed, the Medtech Association, today applauded House of Representatives passage of S. 3971, the Small Business Innovation and Economic Security Act, legislation reauthorizing the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. House passage follows Senate passage earlier this month, bringing the restoration of these initiatives one step closer to completion.
News / Business Development / Small Business
AdvaMed® Welcomes Senate Passage of Legislation Restoring Programs That Jumpstart Early Stage Medtech Innovation
March 4, 2026
WASHINGTON—AdvaMed, the Medtech Association, today welcomed Senate approval of legislation reauthorizing the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs and urged the House of Representatives to act swiftly on passage.